Individualised and Equitable Care of Type 2 Diabetes

Informazioni relative al progetto

EASY-Diabetes

ID dell’accordo di sovvenzione: 877170

DOI

10.3030/877170

Progetto chiuso

Data della firma CE 23 Ottobre 2019

Data di avvio 1 Novembre 2019

Data di completamento 29 Febbraio 2020

Finanziato da

• INDUSTRIAL LEADERSHIP - Innovation In SMEs

Costo totale

€ 71 429,00

Contributo UE

€ 50 000,00

Coordinato da

ADJUVIA AB
Sweden

Periodic Reporting for period 1 - EASY-Diabetes (Individualised and Equitable Care of Type 2 Diabetes)

Periodo di rendicontazione: 2019-11-01 al 2020-02-29

Sintesi del contesto e degli obiettivi generali del progetto

Diabetes is a common chronic disease that causes suffering for patients and vast costs for society. We have developed an e-health solution for diabetes that aims to improve patient outcomes, save time for healthcare professionals and reduce costs for society. Our SME Phase 1 feasibility study aimed to validate the commercial feasibility of our product with target market segments and key stakeholders. It included financial planning and specification of product features.

Lavoro eseguito dall’inizio del progetto fino alla fine del periodo coperto dalla relazione e principali risultati finora ottenuti

In the project, we have assessed the technical, commercial and financial feasibility of introducing our product to the market. This included identifying features needed for a fully commercialised solution, target markets and stakeholders. We have developed a strategy for introducing our product to the market, including regulatory requirements, operating costs and revenue projections.

Progressi oltre lo stato dell’arte e potenziale impatto previsto (incluso l’impatto socioeconomico e le implicazioni sociali più ampie del progetto fino ad ora)

The outcomes of the project resulted in improvements to our plan for the next phase of the business. These improvements include changing some of our target markets, enhancing our implementation models and changing our cooperative strategy. We are thus in a better position to realise the long-term impact of our offering in terms of patient health, healthcare savings and job creation.

Logo for the product